{
  "symbol": "CTKB",
  "company_name": "Cytek Biosciences Inc",
  "ir_website": "https://investors.cytekbio.com/",
  "structured_data": [
    {
      "section_name": "News & Events",
      "links": [
        {
          "title": "Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference",
          "url": "https://investors.cytekbio.com/news-releases/news-release-details/cytek-biosciences-participate-piper-sandler-36th-annual",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![logo](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-color.min.png)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n  * [Overview](/investor-relations \"Main Investor Relations Page\")\n  * [Stock](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Investor Events](/news-events/investor-events)\n    * [Presentations](/news-events/presentations)\n  * [Financials](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Annual Reports](/financial-information/annual-reports)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Governance](/corporate-governance/governance-highlights)\n    * [Governance Highlights](/corporate-governance/governance-highlights)\n    * [Board of Directors](/corporate-governance/board-of-directors)\n    * [Scientific Advisory Board](/corporate-governance/scientific-advisory-board)\n    * [Management Team](https://cytekbio.com/pages/meet-the-team)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Resources](/investor-resources/investor-faqs)\n    * [Investor FAQs](/investor-resources/investor-faqs)\n    * [Email Alerts](/investor-resources/email-alerts)\n    * [Contact IR](/investor-resources/contact-ir)\n\n\n\n  * #  News Release Details \n\n\n\n\n[ « Back to list ](#)\n\n## \n\nCytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference\n\nNov 20, 2024 \n\nFREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Piper Sandler 36th Annual Healthcare Conference in New York, NY.\n\nCytek management is scheduled to participate in a fireside chat on Tuesday, December 3, 2024, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: investors.cytekbio.com.\n\n**About Cytek Biosciences, Inc.**\n\nCytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s FSP platform includes its core instruments, the Cytek Aurora™ and Northern Lights™ systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometer and imaging products under the Amnis® and Guava® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.\n\nCytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).\n\nCytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Enhanced Small Particle, ESP, Amnis and Guava are trademarks of Cytek Biosciences, Inc.\n\nIn addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.\n\n**Media Contact:** Stephanie OlsenLages & Associates(949) 453-8080[stephanie@lages.com](https://www.globenewswire.com/Tracker?data=WS-dRXRmEropcR5Fx2umqZLzzBjgN8YdhFM9OEc0Bn99IdNlch0qaf9GxL9VNzt5OjpxIozN9QZe_6ersK-E5OcFWadh2_Pr39mhssy-AYc=)\n\n**Investor Contact:** Paul GoodsonHead of Investor RelationsCytek Biosciences[pgoodson@cytekbio.com](https://www.globenewswire.com/Tracker?data=ppNQGRcpHxa3__6RCdh1QCoLRcvtiUtOFqRrZRROYWd1cB2Lp4LGHVL-4ms8E5PmDj43MknL5btauicSA9VT6nY4ReuCNGG0UbRM3bt8gKc=)\n\n![](https://ml.globenewswire.com/media/NWQzM2VkYTgtMjM2My00NGU3LThhMDQtZTMyMDk3ZTllMDA5LTExMDczNTc=/tiny/Cytek-Biosciences-Inc-.png)\n\n[](/investor-resources/email-alerts \"Email Alerts\")\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/investor-resources/contact-ir \"Contact IR\")\n\n[](/search \"Search\")\n\n### Search Investor Relations\n\n×\n"
        },
        {
          "title": "Click here for webcast",
          "url": "https://event.webcasts.com/starthere.jsp?ei=1699131&tp_key=db875c5c7f",
          "content": "![](https://cache.webcasts.com/content/gwgg002/1699131/content/db875c5c7f7feccd4f0eaa37542eb2d05b3d7dc0/banner/HealthcareWebcastBanner2024.png)\n\n# Cytek BioSciences, Inc. (CTKB)\n\n## Tue, Dec 3, 2024 4:30 PM EST (Wed, Dec 4, 2024 3:00 AM Asia/Calcutta) \n\n[![Add to Calendar](https://event.webcasts.com/images/btn_add-to-calendar.png) Add to Calendar](https://event.webcasts.com/viewer/vcs.jsp?ei=1699131&reminderid=0)\n\n## Already Registered? Log In Now\n\nEmail:\n\n## Complete this form to enter the webcast.  (* indicates required field)\n\nFirst Name*: Last Name*: Company*: Email*:\n\n[FAQs and System Test](#)\n\n[![Webcast by GlobalMeet](/viewer/images/webcastbygm.png)](https://www.globalmeet.com)\n\n  * [Outlook ❯](#)\n  * [Google ❯](#)\n\n\n"
        },
        {
          "title": "UBS Global Healthcare Conference",
          "url": "https://investors.cytekbio.com/events/event-details/ubs-global-healthcare-conference",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![logo](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-color.min.png)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n  * [Overview](/investor-relations \"Main Investor Relations Page\")\n  * [Stock](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Investor Events](/news-events/investor-events)\n    * [Presentations](/news-events/presentations)\n  * [Financials](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Annual Reports](/financial-information/annual-reports)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Governance](/corporate-governance/governance-highlights)\n    * [Governance Highlights](/corporate-governance/governance-highlights)\n    * [Board of Directors](/corporate-governance/board-of-directors)\n    * [Scientific Advisory Board](/corporate-governance/scientific-advisory-board)\n    * [Management Team](https://cytekbio.com/pages/meet-the-team)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Resources](/investor-resources/investor-faqs)\n    * [Investor FAQs](/investor-resources/investor-faqs)\n    * [Email Alerts](/investor-resources/email-alerts)\n    * [Contact IR](/investor-resources/contact-ir)\n\n\n\n  * #  Event Details \n\n\n\n\n[ « Back to list ](#)\n\n##  UBS Global Healthcare Conference \n\nNov 13, 2024 at 4:15 PM PST \n\n[Click here for webcast](https://event.webcasts.com/starthere.jsp?ei=1697031&tp_key=fe693b3e77&tp_special=8)\n\n[](/investor-resources/email-alerts \"Email Alerts\")\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/investor-resources/contact-ir \"Contact IR\")\n\n[](/search \"Search\")\n\n### Search Investor Relations\n\n×\n"
        },
        {
          "title": "Guggenheim Inaugural Healthcare Conference",
          "url": "https://investors.cytekbio.com/events/event-details/guggenheim-inaugural-healthcare-conference",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![logo](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-color.min.png)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n  * [Overview](/investor-relations \"Main Investor Relations Page\")\n  * [Stock](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Investor Events](/news-events/investor-events)\n    * [Presentations](/news-events/presentations)\n  * [Financials](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Annual Reports](/financial-information/annual-reports)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Governance](/corporate-governance/governance-highlights)\n    * [Governance Highlights](/corporate-governance/governance-highlights)\n    * [Board of Directors](/corporate-governance/board-of-directors)\n    * [Scientific Advisory Board](/corporate-governance/scientific-advisory-board)\n    * [Management Team](https://cytekbio.com/pages/meet-the-team)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Resources](/investor-resources/investor-faqs)\n    * [Investor FAQs](/investor-resources/investor-faqs)\n    * [Email Alerts](/investor-resources/email-alerts)\n    * [Contact IR](/investor-resources/contact-ir)\n\n\n\n  * #  Event Details \n\n\n\n\n[ « Back to list ](#)\n\n##  Guggenheim Inaugural Healthcare Conference \n\nNov 11, 2024 at 11:00 AM EST \n\n[Click here for webcast](https://wsw.com/webcast/guggen/register.aspx?conf=guggen&page=ctkb&url=https%3A//wsw.com/webcast/guggen/ctkb/1927284)\n\n[](/investor-resources/email-alerts \"Email Alerts\")\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/investor-resources/contact-ir \"Contact IR\")\n\n[](/search \"Search\")\n\n### Search Investor Relations\n\n×\n"
        },
        {
          "title": "Click here for webcast",
          "url": "https://wsw.com/webcast/guggen/register.aspx?conf=guggen&page=ctkb&url=https%3A//wsw.com/webcast/guggen/ctkb/1927284",
          "content": "![Header Logo](images/logo.png)\n\n![](images/mobile-logo.png)\n\n# Registration for Webcasting Access Guggenheim Healthcare Innovation Conference\n\nCytek Biosciences \n\nPresenting at: 11/11/2024 11:00 AM (ET)\n\nFirst Name First name required.\n\nLast Name Last name required.\n\nCompany Company name required.\n\nE-mail E-mail required. Email is not valid\n\nYou must have cookies enabled in order to register for this event.\n\n![Summitcast](/images/summitcast_logo_sm_black.png)\n\n[![Summitcast](/images/resources/images/summitcast_logo_md_white.png)](https://twstevents.com/divisions/summitcast/)© 2024 twstevents.com - Unauthorized recording or downloading of this event is not permitted. \n"
        }
      ]
    },
    {
      "section_name": "Financials",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://investors.cytekbio.com/financial-information/sec-filings",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![logo](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-color.min.png)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n  * [Overview](/investor-relations \"Main Investor Relations Page\")\n  * [Stock](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Investor Events](/news-events/investor-events)\n    * [Presentations](/news-events/presentations)\n  * [Financials](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Annual Reports](/financial-information/annual-reports)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Governance](/corporate-governance/governance-highlights)\n    * [Governance Highlights](/corporate-governance/governance-highlights)\n    * [Board of Directors](/corporate-governance/board-of-directors)\n    * [Scientific Advisory Board](/corporate-governance/scientific-advisory-board)\n    * [Management Team](https://cytekbio.com/pages/meet-the-team)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Resources](/investor-resources/investor-faqs)\n    * [Investor FAQs](/investor-resources/investor-faqs)\n    * [Email Alerts](/investor-resources/email-alerts)\n    * [Contact IR](/investor-resources/contact-ir)\n\n\n\n  * # SEC Filings\n\n\n\n\nGroup 3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements\n\nFiling year - Any -20242023202220212020\n\n- Any -\n\nItems per page 102550\n\n10\n\n[Filing date ](?items_per_page=10&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | [Form](?items_per_page=10&order=field_nir_sec_form&sort=asc \"sort by Form\") | [Description](?items_per_page=10&order=field_nir_sec_description&sort=asc \"sort by Description\") | Filing Group | View  \n---|---|---|---|---  \nNov 20, 2024 | [4](/sec-filings/sec-filing/4/0001415889-24-027364) | Statement of changes in beneficial ownership of securities |  3,4,5 | [View HTML](/node/9506/html) [0001415889-24-027364.pdf](/static-files/646cecac-90e7-49a5-a97c-c509e926540c) [0001415889-24-027364.rtf](/static-files/021adc22-628d-484a-adc1-8f60bf17646e) [0001415889-24-027364.xls](/static-files/83faeb43-66e5-4b67-94f2-298ffa676485)  \nNov 20, 2024 | [4](/sec-filings/sec-filing/4/0001415889-24-027365) | Statement of changes in beneficial ownership of securities |  3,4,5 | [View HTML](/node/9511/html) [0001415889-24-027365.pdf](/static-files/f62e1606-1c46-4cc2-ab03-fa439f50c3b0) [0001415889-24-027365.rtf](/static-files/6ee2214f-0cac-4bb2-a4d3-5ee513d916f8) [0001415889-24-027365.xls](/static-files/7d19fcd2-57b5-4678-bf91-82c6c1f6cf52)  \nNov 20, 2024 | [4](/sec-filings/sec-filing/4/0001415889-24-027367) | Statement of changes in beneficial ownership of securities |  3,4,5 | [View HTML](/node/9516/html) [0001415889-24-027367.pdf](/static-files/e9ce0b29-ec6f-4222-8655-ab36001b0266) [0001415889-24-027367.rtf](/static-files/83c62e6d-60b5-4e86-b586-6d10a8eba359) [0001415889-24-027367.xls](/static-files/07ecc498-2efd-4b53-9a63-7c30104f462e)  \nNov 20, 2024 | [4](/sec-filings/sec-filing/4/0001415889-24-027366) | Statement of changes in beneficial ownership of securities |  3,4,5 | [View HTML](/node/9521/html) [0001415889-24-027366.pdf](/static-files/1a87a855-c221-4bf7-9373-6f5790201b09) [0001415889-24-027366.rtf](/static-files/2402b822-7b2c-4198-a125-5898fb2f27b4) [0001415889-24-027366.xls](/static-files/c9ec1845-07e3-48a3-8806-3d19f0b161aa)  \nNov 20, 2024 | [4](/sec-filings/sec-filing/4/0001415889-24-027368) | Statement of changes in beneficial ownership of securities |  3,4,5 | [View HTML](/node/9526/html) [0001415889-24-027368.pdf](/static-files/42740aa9-0a80-45dd-a107-c6dda56eeae1) [0001415889-24-027368.rtf](/static-files/833b16aa-2339-4422-a2e2-c1e98d5a2bce) [0001415889-24-027368.xls](/static-files/2646a6ab-12ee-43d5-ba74-b0d09aa30191)  \nNov 20, 2024 | [4](/sec-filings/sec-filing/4/0001415889-24-027369) | Statement of changes in beneficial ownership of securities |  3,4,5 | [View HTML](/node/9531/html) [0001415889-24-027369.pdf](/static-files/8f4ce0e0-14f9-4ac4-892f-f13a3cb427ca) [0001415889-24-027369.rtf](/static-files/28c37880-8410-47fd-8bf5-0e91018453a3) [0001415889-24-027369.xls](/static-files/c8c4e60d-9084-4304-9b71-7f2f5c876f7c)  \nNov 14, 2024 | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0001398344-24-020821) | An amendment to the SC 13G filing |  Other | [View HTML](/node/9466/html) [0001398344-24-020821.pdf](/static-files/d8fec92f-624c-4d09-ae91-50b0e95433f3) [0001398344-24-020821.rtf](/static-files/268736d5-8de6-4923-b500-23160d0a4b4f) [0001398344-24-020821.xls](/static-files/fcd84fbd-da51-41bc-9fe0-a9757f25a740)  \nNov 14, 2024 | [SC 13G](/sec-filings/sec-filing/sc-13g/0000902664-24-006628) | A statement of beneficial ownership of common stock by certain persons |  Other | [View HTML](/node/9471/html) [0000902664-24-006628.pdf](/static-files/b9dbc07a-839b-47b1-bcd4-8c2050d13b7a) [0000902664-24-006628.rtf](/static-files/4debf92a-2320-4945-9935-2b026117b7c8) [0000902664-24-006628.xls](/static-files/c1841240-cc2c-401d-8f3a-282cfbf98924)  \nNov 07, 2024 | [10-Q](/sec-filings/sec-filing/10-q/0001628280-24-045834) | Quarterly report which provides a continuing view of a company's financial position |  Quarterly Filings | [View HTML](/node/9446/html) [0001628280-24-045834.pdf](/static-files/373da648-1843-4afe-b63e-1ae764f2ed9e) [0001628280-24-045834.rtf](/static-files/57ab537e-92d7-419f-8b45-bdc5a1555682) [0001628280-24-045834.xls](/static-files/766405af-7195-4f5a-8dd9-811874b5dc4c) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0001628280-24-045834)  \nNov 05, 2024 | [8-K](/sec-filings/sec-filing/8-k/0001193125-24-251268) | Report of unscheduled material events or corporate event |  Current Reports | [View HTML](/node/9441/html) [0001193125-24-251268.pdf](/static-files/ae952307-ec8e-43e1-9afb-ec85a2729f82) [0001193125-24-251268.rtf](/static-files/a77b2f22-5bfd-4ee2-b633-cb4ec61cf98b) [0001193125-24-251268.xls](/static-files/57114310-f6e5-469f-a72c-7835c189c57b) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001193125-24-251268)  \n  \nDisplaying 1 - 10 of 333 results\n\nData provided by [Kaleidoscope](https://www.kscope.io).\n\n[](/investor-resources/email-alerts \"Email Alerts\")\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/investor-resources/contact-ir \"Contact IR\")\n\n[](/search \"Search\")\n\n### Search Investor Relations\n\n×\n"
        },
        {
          "title": "Quarterly Results",
          "url": "https://investors.cytekbio.com/financial-information/quarterly-results",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![logo](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-color.min.png)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n  * [Overview](/investor-relations \"Main Investor Relations Page\")\n  * [Stock](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Investor Events](/news-events/investor-events)\n    * [Presentations](/news-events/presentations)\n  * [Financials](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Annual Reports](/financial-information/annual-reports)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Governance](/corporate-governance/governance-highlights)\n    * [Governance Highlights](/corporate-governance/governance-highlights)\n    * [Board of Directors](/corporate-governance/board-of-directors)\n    * [Scientific Advisory Board](/corporate-governance/scientific-advisory-board)\n    * [Management Team](https://cytekbio.com/pages/meet-the-team)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Resources](/investor-resources/investor-faqs)\n    * [Investor FAQs](/investor-resources/investor-faqs)\n    * [Email Alerts](/investor-resources/email-alerts)\n    * [Contact IR](/investor-resources/contact-ir)\n\n\n\n  * # Quarterly Results\n\n\n\n\n“Please see SEC Filings” for our quarterly reports on Form 10-Q.\n\n[Show all](#)\n\n2024\n\nQ3\n\n  * [Cytek Biosciences Third Quarter 2024 Earnings Conference Call](/events/event-details/cytek-biosciences-third-quarter-2024-earnings-conference-call)\n\n  * [Cytek Biosciences Reports Third Quarter 2024 Financial Results](/news-releases/news-release-details/cytek-biosciences-reports-third-quarter-2024-financial-results)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001628280-24-045834)\n\n\n\n\nQ2\n\n  * [Cytek Biosciences Second Quarter 2024 Earnings Conference Call](/events/event-details/cytek-biosciences-second-quarter-2024-earnings-conference-call)\n\n  * [Cytek Biosciences Reports Second Quarter 2024 Financial Results](/news-releases/news-release-details/cytek-biosciences-reports-second-quarter-2024-financial-results)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001628280-24-035264)\n\n\n\n\nQ1\n\n  * [Cytek Biosciences First Quarter 2024 Earnings Conference Call](/events/event-details/cytek-biosciences-first-quarter-2024-earnings-conference-call)\n\n  * [Cytek Biosciences Reports First Quarter 2024 Financial Results](/news-releases/news-release-details/cytek-biosciences-reports-first-quarter-2024-financial-results)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001628280-24-021723)\n\n\n\n\n2023\n\nQ4\n\n  * [Form 10-K](/sec-filings/sec-filing/10-k/0001628280-24-010933)\n\n\n\n\nQ3\n\n  * [Cytek Biosciences Third Quarter 2023 Earnings Conference Call](/events/event-details/cytek-biosciences-third-quarter-2023-earnings-conference-call)\n\n  * [Cytek Biosciences Reports Third Quarter 2023 Financial Results](/news-releases/news-release-details/cytek-biosciences-reports-third-quarter-2023-financial-results)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001628280-23-038974)\n\n\n\n\nQ2\n\n  * [Cytek Biosciences Second Quarter 2023 Earnings Conference Call](/events/event-details/cytek-biosciences-second-quarter-2023-earnings-conference-call)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0000950170-23-039899)\n\n\n\n\nQ1\n\n  * [Cytek Biosciences First Quarter 2023 Earnings Conference Call](/events/event-details/cytek-biosciences-first-quarter-2023-earnings-conference-call)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0000950170-23-019777)\n\n\n\n\n2022\n\nQ4\n\n  * [Cytek Biosciences Fourth Quarter and Full Year 2022 Earnings Conference Call](/events/event-details/cytek-fourth-quarter-full-year-2022-earnings-conference-call)\n\n  * [Form 10-K](/sec-filings/sec-filing/10-k/0000950170-23-005610)\n\n\n\n\nQ3\n\n  * [Cytek Biosciences Third Quarter 2022 Earnings Conference Call](/events/event-details/cytek-biosciences-third-quarter-2022-earnings-conference-call)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0000950170-22-023935)\n\n\n\n\nQ2\n\n  * [Cytek Biosciences Second Quarter 2022 Earnings Conference Call](/events/event-details/cytek-biosciences-second-quarter-2022-earnings-conference-call)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0000950170-22-016500)\n\n\n\n\nQ1\n\n  * [Cytek Biosciences First Quarter 2022 Earnings Conference Call](/events/event-details/cytek-biosciences-first-quarter-2022-earnings-conference-call)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0000950170-22-009425)\n\n\n\n\n2021\n\nQ4\n\n  * [Cytek Biosciences Fourth Quarter 2021 Earnings Conference Call](/events/event-details/cytek-biosciences-fourth-quarter-2021-earnings-conference-call)\n\n  * [Form 10-K](/sec-filings/sec-filing/10-k/0000950170-22-004106)\n\n\n\n\nQ3\n\n  * [Cytek Biosciences Third Quarter 2021 Earnings Conference Call](/events/event-details/cytek-biosciences-third-quarter-2021-earnings-conference-call)\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0000950170-21-004256)\n\n\n\n\n[](/investor-resources/email-alerts \"Email Alerts\")\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/investor-resources/contact-ir \"Contact IR\")\n\n[](/search \"Search\")\n\n### Search Investor Relations\n\n×\n"
        },
        {
          "title": "Annual Reports",
          "url": "https://investors.cytekbio.com/financial-information/annual-reports",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![logo](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-color.min.png)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n[![](/sites/g/files/knoqqb65706/themes/site/nir_pid4248/dist/images/CytekLogo-white.min.png)](http://cytekbio.com)\n\n  * [Overview](/investor-relations \"Main Investor Relations Page\")\n  * [Stock](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Investor Events](/news-events/investor-events)\n    * [Presentations](/news-events/presentations)\n  * [Financials](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Annual Reports](/financial-information/annual-reports)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Governance](/corporate-governance/governance-highlights)\n    * [Governance Highlights](/corporate-governance/governance-highlights)\n    * [Board of Directors](/corporate-governance/board-of-directors)\n    * [Scientific Advisory Board](/corporate-governance/scientific-advisory-board)\n    * [Management Team](https://cytekbio.com/pages/meet-the-team)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Resources](/investor-resources/investor-faqs)\n    * [Investor FAQs](/investor-resources/investor-faqs)\n    * [Email Alerts](/investor-resources/email-alerts)\n    * [Contact IR](/investor-resources/contact-ir)\n\n\n\n  * # Annual Reports\n\n\n\n\nDate  |  Title   \n---|---  \nJun 06, 2024 |  [2023 Annual Report](/static-files/96bdf51e-e341-4fc5-8731-7bc61ca633e8)  \nJun 20, 2023 |  [2022 Annual Report](/static-files/361d95fa-45f6-4284-b64a-82ff11bf3571)  \nJun 14, 2022 |  [2021 Annual Report ](/static-files/68db0e2a-8b5b-43a7-b4ab-144f9ed1b151)  \n  \n[](/investor-resources/email-alerts \"Email Alerts\")\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/investor-resources/contact-ir \"Contact IR\")\n\n[](/search \"Search\")\n\n### Search Investor Relations\n\n×\n"
        }
      ]
    }
  ]
}